New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
07:19 EDTZMHZimmer Biomet deal very positive, says Bernstein
After Zimmer agreed to buy Biomet, Bernstein thinks the deal will be 17% accretive to cash EPS in the first year and 24% accretive in the second year. The firm expects Zimmer's stock to rise further as a result of the deal, and keeps an Outperform rating on the shares.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2015
14:48 EDTZMHZimmer, Stryker have mixed read through from J&J results, says Wells Fargo
Subscribe for More Information
April 13, 2015
17:07 EDTZMHZimmer announces extension of outside date for pending Biomet merger
Subscribe for More Information
April 9, 2015
09:25 EDTZMHBiomet results positive for Zimmer deal accretion, says Wells Fargo
Wells Fargo says the key takeaway from Bioment's Q3 results this morning was the company's "significant" margin improvement. The results give Wells more confidence that Zimmer's earnings accretion estimate for the acquisition is attainable and could mean potential upside.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use